Chat with us, powered by LiveChat

Takeda to buy Nycomed for $13.6 billion

Takeda Pharmaceutical Co., Japan’s largest drugmaker, is buying privately held Swiss rival Nycomed for $13.6 billion, giving it access to a newly approved lung-disease drug, which is expected to be a major source of revenue growth. more